Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa

South African Journal of Psychiatry

 
 
Field Value
 
Title Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa
 
Creator Veyej, Nabila Moosa, Mahomed Y.H.
 
Subject Psychiatry; Community Psychiatry long-acting injectable antipsychotics; community clinics; nonadherence; co-prescribing; Africa
Description Background: Long-acting injectable antipsychotics (LAI – APs) improve adherence to antipsychotics and decrease functional decline in schizophrenia. Yet they are prescribed late, in patients with established functional decline. Although LAI – APs are widely prescribed in South Africa, there is a paucity of research regarding the prescription profile for LAI – APs.Aim: This study aimed to describe prescribing practices for LAI – APs at psychiatric clinics.Setting: Community psychiatric clinics in South Africa.Methods: A retrospective review of the psychiatric files of all patients on LAI – APs attending the clinics over the study period was conducted. Sociodemographic, clinical and pharmacological information regarding the LAI – AP prescribed was extracted from the files.Results: A total of 206 charts were examined. The mean age of the study population was 46 (SD ± 12) years. Significantly more patients were male (n = 154; 74.8%), single (n = 184, 89.3%) and unemployed (n = 115; 55.8%) (p  0.001). Approximately half had a comorbid substance use disorder (47.6%). The most common indication for the prescription of a LAI – AP was non-adherence (66%). Only 9.7% of the patients were prescribed a LAI – AP alone. No significant socio-demographic or clinical characteristic was associated with this prescribing habit. A LAI – AP was prescribed in combination with an oral antipsychotic, mood stabiliser or antidepressant in 53.9%, 44.7% and 7.8% of patients, respectively.Conclusion: Long-acting injectable antipsychotics were prescribed mainly following noncompliance with oral antipsychotics and may represent a missed opportunity to prevent functional decline. The high prevalence of LAI – AP polypharmacy has been highlighted.
 
Publisher AOSIS
 
Contributor
Date 2022-06-30
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Retrospective Chart Review
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajpsychiatry.v28i0.1809
 
Source South African Journal of Psychiatry; Vol 28 (2022); 9 pages 2078-6786 1608-9685
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajp.org.za/index.php/sajp/article/view/1809/2671 https://sajp.org.za/index.php/sajp/article/view/1809/2672 https://sajp.org.za/index.php/sajp/article/view/1809/2673 https://sajp.org.za/index.php/sajp/article/view/1809/2674
 
Coverage Africa; South Africa; Johannesburg 2019 Age; Gender; Marital Status; Employment; Education; Race; Primary Psychiatric Disorder; Duration of Illness; Comorbid Psychiatric Illness; Comorbid Medical Illness
Rights Copyright (c) 2022 Nabila Veyej, Mahomed Y.H. Moosa https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT